Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Editorial: The emerging discipline of quantitative systems pharmacology
Tarek A. Leil, Sergey Ermakov
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 19

Showing 19 citing articles:

Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Houman Savoji, Mohammad Hossein Mohammadi, Naimeh Rafatian, et al.
Biomaterials (2018) Vol. 198, pp. 3-26
Open Access | Times Cited: 191
The promises of quantitative systems pharmacology modelling for drug development
Vincent Knight-Schrijver, Vijayalakshmi Chelliah, L. Cucurull-Sanchez, et al.
Computational and Structural Biotechnology Journal (2016) Vol. 14, pp. 363-370
Open Access | Times Cited: 89
Recent applications of quantitative systems pharmacology and machine learning models across diseases
Sara Sadat Aghamiri, Rada Amin, Tomáš Helikar
Journal of Pharmacokinetics and Pharmacodynamics (2021) Vol. 49, Iss. 1, pp. 19-37
Open Access | Times Cited: 41
Path Topology in Molecular and Materials Sciences
Dong Chen, Jian Liu, Jie Wu, et al.
The Journal of Physical Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 954-964
Open Access | Times Cited: 21
Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition
Hanwen Wang, Theinmozhi Arulraj, Holly Kimko, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 20
Recent developments in using mechanistic cardiac modelling for drug safety evaluation
Mark Davies, Ken Wang, Gary R. Mirams, et al.
Drug Discovery Today (2016) Vol. 21, Iss. 6, pp. 924-938
Open Access | Times Cited: 60
Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson’s Disease
Gabriela Pérez-Barrón, Sergio Montes, Yoshajandith Aguirre-Vidal, et al.
Neurochemical Research (2021) Vol. 46, Iss. 11, pp. 2923-2935
Closed Access | Times Cited: 20
Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure
Limei Cheng, Yuchi Qiu, Brian J. Schmidt, et al.
Journal of Pharmacokinetics and Pharmacodynamics (2021) Vol. 49, Iss. 1, pp. 39-50
Open Access | Times Cited: 17
Development of quantitative systems pharmacology and toxicology models within consortia: experiences and lessons learned through DILIsym development
Brett A. Howell, Scott Q. Siler, Hugh A. Barton, et al.
Drug Discovery Today Disease Models (2016) Vol. 22, pp. 5-13
Closed Access | Times Cited: 13
Virtual Lobule Models Are the Key for Multiscale Biomechanical and Pharmacological Modeling for the Liver
Harvey Ho, En Zhang
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 10
The Virtual Anemia Trial: An Assessment of Model‐Based In Silico Clinical Trials of Anemia Treatment Algorithms in Patients With Hemodialysis
Doris H. Fuertinger, Alice Topping, Franz Kappel, et al.
CPT Pharmacometrics & Systems Pharmacology (2018) Vol. 7, Iss. 4, pp. 219-227
Open Access | Times Cited: 8
Pharmacodynamic Drug–Drug Interactions
Ming Zheng
Springer eBooks (2018), pp. 1-10
Closed Access | Times Cited: 8
A quantitative systems pharmacology (QSP) model for Pneumocystis treatment in mice
Guan‐Sheng Liu, Richard Ballweg, Alan Ashbaugh, et al.
BMC Systems Biology (2018) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Combinatorial approaches for novel cardiovascular drug discovery: a review of the literature
Simone Brogi, Rita Tabanelli, Vincenzo Calderone
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 10, pp. 1111-1129
Closed Access | Times Cited: 4
Cardiovascular Drugs: an Insight of In Silico Drug Design Tools
Himangshu Sarma, Mohan Upadhyaya, Bitu Gogoi, et al.
Journal of Pharmaceutical Innovation (2021) Vol. 17, Iss. 4, pp. 1484-1509
Closed Access | Times Cited: 5
Hormesis, Resilience and Mental Health: Enhancing Public Health and Therapeutic Options
Vittorio Calabrese, Maria Scuto, Edward J. Calabrese
Healthy ageing and longevity (2020), pp. 497-520
Closed Access | Times Cited: 3
Use of statistical and pharmacokinetic–pharmacodynamic modeling and simulation to improve decision-making: A section summary report of the trends and innovations in clinical trial statistics conference
Holly Kimko, Seth Berry, Michael O’Kelly, et al.
Journal of Biopharmaceutical Statistics (2017) Vol. 27, Iss. 3, pp. 554-567
Closed Access | Times Cited: 2
Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition
Hanwen Wang, Theinmozhi Arulraj, Holly Kimko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Applying Quantitative Systems Pharmacology (QSP) Modeling to Understand the Treatment of Pneumocystis
Tongli Zhang
Springer eBooks (2021), pp. 229-243
Closed Access
Page 1

Scroll to top